London Stock Exchange Group (LSEG) announced today that it has agreed to acquire Quantile Group Limited. Founded in 2015, Quantile is one of the world’s prominent providers of portfolio and margin services for the global financial services sector.

Through the acquisition of Quantile, LSEG is planning to enhance its range of post-trade risk management solutions. Additionally, the London Stock Exchange Group outlined the importance of providing innovative post-trade risk management tools in today’s financial infrastructure.

As far as financial details of the acquisition are concerned, LSEG has agreed to pay a maximum aggregate consideration of up to £274 million (subject to customary adjustments) to Quantile's shareholders. For the mentioned transaction, Evercore is acting as the sole financial adviser.

"The acquisition of Quantile builds on the strong growth delivered by LSEG and our Post Trade division. It significantly enhances LSEG's multi-asset class customer offering across the transaction lifecycle by providing more sophisticated tools and infrastructure for customers to optimize their financial resources and drive greater operational efficiencies in OTC derivatives. I look forward to working with Andy and his team at Quantile to further support innovation for the market and develop our businesses,” Daniel Maguire, Group Head, Post Trade, LSEG & CEO, LCH Group, commented.

Transaction

According to LSEG, the transaction is expected to close in 2022. The Group is planning to fund the acquisition through existing cash resources and credit facilities. After the completion of the transaction, Quantile will remain a standalone entity within the Group's Post Trade division.

"I am delighted with this agreement to become part of LSEG. Quantile and LSEG share many of the same values, including a culture of innovation and a focus on delivering market-leading services. I look forward to working with Daniel and the team to accelerate our growth and to continue to deliver efficiencies and portfolio optimization for our customers and the wider OTC derivatives marketplace,” Andrew Williams, the CEO of Quantile, said.